Scientists at the University of Edinburgh have made strides in treating advanced liver disease with a new cell therapy. This innovative approach could provide an alternative to liver transplants, offering hope for many patients.
The therapy uses the body’s own immune cells, specifically mature macrophages. These cells are designed to degrade scar tissue in the liver and encourage the growth of healthy liver cells. This could help restore liver function for those with severe liver issues.
In a clinical trial named MATCH, researchers tested this therapy on 26 patients, while 24 others received standard care. Four years later, results showed that 70% of those who received the cell therapy were still alive without needing a transplant. In contrast, only 40% of the standard care group fared the same.
The therapy group recorded eight deaths, while the standard care group had nine deaths and five transplants. Importantly, no serious side effects were noted in the therapy group, suggesting it is a safe option.
Dr. Stuart Forbes, director of the Institute for Regeneration and Repair, emphasized the need for alternatives to liver transplants due to a shortage of donor organs. Many patients die waiting for transplants, so new treatments are essential. He is optimistic that macrophage therapy could expand treatment options for patients, potentially lowering the demand for transplants.
The research involved collaboration with institutions like the Scottish National Blood Transfusion Service and received funding from the Medical Research Council. Findings were published in the Cell Stem Cell journal and highlighted in discussions around innovative treatments for liver conditions.
Interestingly, there has been public interest and discussion on social media regarding new treatment options for liver diseases. Many patients and advocacy groups are eager for alternatives as they navigate their health challenges.
In the broader context, liver disease remains a significant health issue globally. According to the World Health Organization, liver-related diseases cause over 2 million deaths each year. As we look to the future, advancements like macrophage therapy could play a crucial role in changing these statistics and improving patients’ lives.
For more information about the ongoing research in cell therapy, visit Cell Stem Cell.
